HB 1130 establishes a prioritization system for individuals with developmental disabilities seeking home and community-based services waivers in Washington State. It directs the Developmental Disabilities Administration to prioritize specific populations, such as those over age 45, individuals discharging from institutional settings, or those without a safe hospital discharge plan. The bill also mandates the administration to align its rules with this prioritization and to routinely collect and publicly report data on waiver enrollment, waitlists, and unfulfilled service requests. This aims to ensure that individuals identified as most in need receive timely access to critical support services.
HB 1813 realigns the administration of behavioral health crisis services for Medicaid enrollees in Washington state. Beginning January 1, 2027, behavioral health administrative services organizations (BHASOs) will contract to administer these crisis services, taking over from managed care organizations. The bill requires a comprehensive funding analysis by January 1, 2026, to ensure BHASOs can adequately support all individuals needing behavioral health services, regardless of insurance status. It also mandates a transition plan for this shift and directs the development of a strategic plan for the future reprocurement of all medical assistance services, including stakeholder input.
SB 5337 establishes a state certification for memory care services provided by licensed assisted living facilities in Washington. This bill aims to standardize memory care definitions and help consumers make informed choices for individuals with dementia. After July 1, 2026, facilities advertising or operating memory care units must be certified, requiring them to meet specific standards for physical infrastructure, staffing levels, and policies for resident safety and behavior. Certified facilities must also provide regular resident assessments, ensure staff complete annual dementia-related continuing education, and offer daily programming with varied activities tailored to residents' needs.
HB 1971 requires health plans to provide reimbursement for a 12-month refill of covered prescription hormone therapy, obtained at one time, for their enrollees. This aims to increase access to these medications for patients of all ages. Starting January 1, 2026, health plans must comply, unless the enrollee requests a smaller supply, the provider instructs a smaller supply, or the therapy is a controlled substance. The 12-month supply applies to medications that can be safely stored at room temperature, while controlled substances must be covered for the maximum refill allowed by law. Prescription hormone therapy is defined as FDA-approved drugs that medically adjust hormone levels, excluding certain glucagon-like peptide-1 medications.
Senate Bill 5480 aims to protect consumers by establishing new rules for medical debt. It updates the definition of "medical debt" and outlines specific provisions for how it can be handled. A central aspect of the bill makes medical debt void and unenforceable if a health care provider, facility, or collection agency unlawfully reports information about that debt to a consumer credit reporting agency. This legislation directly affects individuals with medical debt and the agencies involved in its collection and reporting.
Senate Joint Memorial 8004 is a petition from the Washington State Legislature to the federal government regarding universal health care. It requests that the federal government either establish a national universal health care program for all U.S. residents, or partner with Washington state to reduce barriers for the state to implement its own universal health system. Failing those, the memorial asks the federal government to grant Washington state the necessary waivers to create its own universal health care system.
House Bill 1531 establishes a state policy that public health responses to communicable diseases must be guided by the best available science and evidence-based measures, including immunizations and vaccines. It requires state and local health officials to implement and promote these measures within available resources. The bill also prohibits the state or any local government from enacting laws or policies that forbid the implementation and promotion of such measures, declaring any existing prohibitive policies null and void. This legislation clarifies the ability of public health officials to use scientifically proven methods to control disease spread, without creating new requirements for individuals to receive vaccines.
Substitute House Bill 1669 mandates that health plans offered in Washington's large and small group markets must provide coverage for medically necessary prosthetic limbs and custom orthotic braces. This directly affects individuals enrolled in these plans by ensuring access to devices needed for daily living, job-related tasks, and various physical activities. The bill requires coverage for materials, instruction, and reasonable repair or replacement, including replacements due to changes in a patient's condition or significant device damage. It also prohibits denying coverage to enrollees with disabilities if similar services would be covered for non-disabled individuals, while allowing for standard utilization management. These requirements apply to plans issued or renewed on or after January 1, 2026.
House Bill 1215 modifies Washington state's Natural Death Act by changing the model health care directive form, often referred to as a living will. The bill removes a specific section which currently states that a directive has no legal effect if the person who created it is diagnosed as pregnant. This change ensures that an individual's end-of-life health care directives remain valid regardless of pregnancy status.
HB 1209 regulates the sale and transfer of sodium nitrite (a chemical used in food preservation and industry) by requiring warning labels on products containing over 10% sodium nitrite and restricting sales to commercial businesses. It mandates that sellers verify a buyer’s commercial need using an employer ID number, banning sales to individuals or non-verified entities. The law requires labels stating "WARNING: Deadly if ingested. Seek immediate medical attention..." to alert users about severe health risks, including methemoglobinemia. The bill, effective April 7, 2025, directly affects retailers, online sellers, and commercial users of sodium nitrite while aiming to reduce suicide-related deaths linked to its misuse.
